Álvaro Zarauza

Factors related to the success or failure of cardioversion in atrial fibrillation and emergency department revisit according to restoration of sinus rhythm: analysis of the URGFAICS cohort

J. Jacob, A. Esquerrà, I. Cabello, 2022 .

Emergency Department capacity to initiate thromboprophylaxis in patients with atrial fibrillation and thrombotic risk after discharge: URGFAICS cohort analysis

J. Jacob, A. Esquerrà, I. Cabello, 2021, Internal and Emergency Medicine.

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

C. Tebé, M. Gasa, S. Videla, 2022, Trials.

Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial

X. Solanich, F. Llopis, J. Jacob, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.